# Recovery of Oxytocin Responsiveness in Pregnant Human Myometrial Explants After Oxytocin-Induced Desensitization: an In-vitro Analysis of Oxytocin Receptor Expression and Signaling

> **NCT02762669** · NA · TERMINATED · sponsor: **Samuel Lunenfeld Research Institute, Mount Sinai Hospital** · enrollment: 4 (actual)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DRUG:** Oxytocin

## Key facts

- **NCT ID:** NCT02762669
- **Lead sponsor:** Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-08-03
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2024-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02762669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02762669, "Recovery of Oxytocin Responsiveness in Pregnant Human Myometrial Explants After Oxytocin-Induced Desensitization: an In-vitro Analysis of Oxytocin Receptor Expression and Signaling". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02762669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*